Trials / Completed
CompletedNCT04104685
A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam.
A Prospective, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Phase 2 Study to Evaluate the Safety and Efficacy of a Combination of 3% Minocycline and 0.3% Adapalene Topical Foam Formulation for the Treatment of Moderate-to-Severe Acne (Study FX2016 40)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 446 (actual)
- Sponsor
- Vyne Therapeutics Inc. · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
A study comparing FCD105 to 3% minocycline foam, 0.3% adapalene foam and vehicle foam in patients ≥ 12 years old for the treatment of moderate-to-severe acne.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | FCD105 | Experimental combination |
| DRUG | 3% Minocycline Foam | Active Comparator |
| DRUG | 0.3% Adapalene Foam | Active Comparator |
| OTHER | Vehicle Foam | Placebo |
Timeline
- Start date
- 2019-09-18
- Primary completion
- 2020-02-28
- Completion
- 2020-03-03
- First posted
- 2019-09-26
- Last updated
- 2021-02-05
Locations
35 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04104685. Inclusion in this directory is not an endorsement.